A panel of independent experts voted unanimously to recommend the treatment to protect infants from the lung-infecting virus.
CDC director Mandy Cohenand it will be added to the CDC’s childhood immunization schedule. ACIP also unanimously recommended that certain infants between the ages of eight to 19 months should receive a second dose of nirsevimab to help them stay healthy during their second RSV season if they have any underlying health issues that put them at a higher risk of hospitalization.
“As we head into respiratory virus season this fall, it’s important to use these new tools available to help prevent severe RSV illness,” . “I encourage parents of infants to talk to their pediatricians about this new immunization and the importance of preventing severe RSV.”, ACIP also recommended that certain infants ages eight to 19 months get a second dose of nirsevimab to help them through their second RSV season, if they have underlying health issues that put them at higher risk for hospitalization.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Babies should get new drug that prevents RSV, CDC panel saysInfants should get a new drug to protect them against a respiratory virus that sends tens of thousands of American children to the hospital each year, heath advisers recommended Thursday.
Read more »
Babies should get new drug that prevents RSV, CDC panel saysInfants should get a new drug to protect them against a respiratory virus that sends tens of thousands of American children to the hospital each year, health advisers recommended Thursday.
Read more »
Babies born in fall and winter should get RSV shots, CDC panel recommendsMany babies should get a shot soon after birth to protect them from RSV, or respiratory syncytial virus, a panel of the Centers for Disease Control and Prevention's outside advisers voted Thursday.
Read more »
Babies Should Get New Drug That Prevents RSV, CDC Panel SaysAn infection with RSV is a cold-like nuisance for most healthy people, but it can be life-threatening for the very young and the elderly. There are no vaccines for babies, so the new drug is expected to fill a critical need.
Read more »
CDC panel says babies should get new drug that prevents RSVInfants should get a new drug to protect them against a respiratory virus that sends tens of thousands of American children to the hospital each year, heath...
Read more »